Achieve Life Sciences, Inc. (ACHV) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| ORCA-OL enrolled participants | 479.00 | FY2025-Q2 |
| ORCA-3 trial participants | 792.00 | FY2025-Q2 |
| Participants completing one year of cytosinicline treatment | 334.00 | FY2025-Q4 |
| ORCA-OL United States clinical trial sites | 29.00 | FY2025-Q2 |
| ORCA-OL participants completing six months of cytosinicline treatment | 300.00 | FY2025-Q1 |
Back to ACHV overview · ACHV earnings · ACHV holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.